Relationship between obesity, insulin resistance, and coronary heart disease risk

被引:398
作者
Abbasi, F
Brown, BW
Lamendola, C
McLaughlin, T
Reaven, GM
机构
[1] Stanford Univ, Sch Med, Falk CVRC, Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
关键词
D O I
10.1016/S0735-1097(02)02051-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The study goals were to: 1) define the relationship between body mass index (BMI) and insulin resistance in 314 nondiabetic, normotensive, healthy volunteers; and 2) determine the relationship between each of these two variables and coronary heart disease (CHD) risk factors. BACKGROUND The importance of obesity as a risk factor for type 2 diabetes and hypertension is well-recognized, but its role as a CHD risk factor in nondiabetic, normotensive individuals is less well established. METHODS Insulin resistance was quantified by determining the steady-state plasma glucose (SSPG) concentration during the last 30 min of a 180-min infusion of octreotide, glucose, and insulin. In addition, nine CHD risk factors: age, systolic blood pressure, diastolic blood pressure (DBP), total cholesterol, triglycerides (TG), high-density lipoprotein (HDL) cholesterol and low-density lipoprotein cholesterol concentrations, and glucose and insulin responses to a 75-g oral glucose load were measured in the volunteers. RESULTS The BMI and the SSPG concentration were significantly related (r = 0.465, p < 0.001). The BMI and SSPG were both independently associated with each of the nine risk factors. In multiple regression analysis, SSPG concentration added modest to substantial power to BMI with regard to the prediction of DBP, HDL cholesterol and TG concentrations, and the glucose and insulin responses. CONCLUSIONS Obesity and insulin resistance are both powerful predictors of CHD risk, and insulin resistance at any given degree of obesity accentuates the risk of CHD and type 2 diabetes.
引用
收藏
页码:937 / 943
页数:7
相关论文
共 34 条
[11]   WEIGHT AND HYPERTENSION [J].
HAVLIK, RJ ;
HUBERT, HB ;
FABSITZ, RR ;
FEINLEIB, M .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (05) :855-859
[12]  
HOLLENBECK CB, 1991, DIABETES METAB, V17, P483
[13]   Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women [J].
Jeppesen, J ;
Schaaf, P ;
Jones, G ;
Zhou, MY ;
Chen, YDI ;
Reaven, GM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 65 (04) :1027-1033
[14]   Roles of insulin resistance and obesity in regulation of plasma insulin concentrations [J].
Jones, CNO ;
Abbasi, F ;
Carantoni, M ;
Polonsky, KS ;
Reaven, GM .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 278 (03) :E501-E508
[15]   Varying body mass index cutoff points to describe overweight prevalence among US Adults: NHANES III (1988 to 1994) [J].
Kuczmarski, RJ ;
Carroll, MD ;
Flegal, KM ;
Troiano, RP .
OBESITY RESEARCH, 1997, 5 (06) :542-548
[16]   INSULIN-RESISTANCE AND INSULIN SECRETORY DYSFUNCTION AS PRECURSORS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS - PROSPECTIVE STUDIES OF PIMA-INDIANS [J].
LILLIOJA, S ;
MOTT, DM ;
SPRAUL, M ;
FERRARO, R ;
FOLEY, JE ;
RAVUSSIN, E ;
KNOWLER, WC ;
BENNETT, PH ;
BOGARDUS, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (27) :1988-1992
[17]   ADDITIVE EFFECTS OF OBESITY, HYPERTENSION, AND TYPE-2 DIABETES ON INSULIN-RESISTANCE [J].
MAHEUX, P ;
JEPPESEN, J ;
SHEU, WHH ;
HOLLENBECK, CB ;
CLINKINGBEARD, C ;
GREENFIELD, MS ;
CHEN, YDI ;
REAVEN, GM .
HYPERTENSION, 1994, 24 (06) :695-698
[18]   Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women [J].
McLaughlin, T ;
Abbasi, F ;
Carantoni, M ;
Schaaf, P ;
Reaven, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) :578-581
[19]  
MILLER GJ, 1975, LANCET, V1, P16
[20]   EFFECTS OF WEIGHT REDUCTION ON OBESITY - STUDIES OF LIPID AND CARBOHYDRATE-METABOLISM IN NORMAL AND HYPERLIPOPROTEINEMIC SUBJECTS [J].
OLEFSKY, J ;
REAVEN, GM ;
FARQUHAR, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 53 (01) :64-76